TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $12,000 | -25.0% | 647 | -29.0% | 0.00% | – |
| Q3 2020 | $16,000 | -15.8% | 911 | -15.2% | 0.00% | – |
| Q2 2020 | $19,000 | +35.7% | 1,074 | +17.9% | 0.00% | – |
| Q1 2020 | $14,000 | -22.2% | 911 | 0.0% | 0.00% | – |
| Q4 2019 | $18,000 | +12.5% | 911 | 0.0% | 0.00% | – |
| Q3 2019 | $16,000 | 0.0% | 911 | 0.0% | 0.00% | – |
| Q2 2019 | $16,000 | -15.8% | 911 | 0.0% | 0.00% | – |
| Q1 2019 | $19,000 | – | 911 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |